A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer

Breast cancer (BC) is the second leading cause of death among women, and it has become a global health issue due to the increasing number of cases. Different treatment options, including radiotherapy, surgery, chemotherapy and anti-estrogen therapy, aromatase inhibitors, anti-angiogenesis drugs, and...

Full description

Bibliographic Details
Main Authors: Muhammad Naeem, Muhammad Omer Iqbal, Humaira Khan, Muhammad Masood Ahmed, Muhammad Farooq, Muhammad Moeen Aadil, Mohamad Ikhwan Jamaludin, Abu Hazafa, Wan-Chi Tsai
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/11/3412
_version_ 1797492581698895872
author Muhammad Naeem
Muhammad Omer Iqbal
Humaira Khan
Muhammad Masood Ahmed
Muhammad Farooq
Muhammad Moeen Aadil
Mohamad Ikhwan Jamaludin
Abu Hazafa
Wan-Chi Tsai
author_facet Muhammad Naeem
Muhammad Omer Iqbal
Humaira Khan
Muhammad Masood Ahmed
Muhammad Farooq
Muhammad Moeen Aadil
Mohamad Ikhwan Jamaludin
Abu Hazafa
Wan-Chi Tsai
author_sort Muhammad Naeem
collection DOAJ
description Breast cancer (BC) is the second leading cause of death among women, and it has become a global health issue due to the increasing number of cases. Different treatment options, including radiotherapy, surgery, chemotherapy and anti-estrogen therapy, aromatase inhibitors, anti-angiogenesis drugs, and anthracyclines, are available for BC treatment. However, due to its high occurrence and disease progression, effective therapeutic options for metastatic BC are still lacking. Considering this scenario, there is an urgent need for an effective therapeutic strategy to meet the current challenges of BC. Natural products have been screened as anticancer agents as they are cost-effective, possess low toxicity and fewer side effects, and are considered alternative therapeutic options for BC therapy. Natural products showed anticancer activities against BC through the inhibition of angiogenesis, cell migrations, proliferations, and tumor growth; cell cycle arrest by inducing apoptosis and cell death, the downstream regulation of signaling pathways (such as Notch, NF-κB, PI3K/Akt/mTOR, MAPK/ERK, and NFAT-MDM2), and the regulation of EMT processes. Natural products also acted synergistically to overcome the drug resistance issue, thus improving their efficacy as an emerging therapeutic option for BC therapy. This review focused on the emerging roles of novel natural products and derived bioactive compounds as therapeutic agents against BC. The present review also discussed the mechanism of action through signaling pathways and the synergistic approach of natural compounds to improve their efficacy. We discussed the recent in vivo and in vitro studies for exploring the overexpression of oncogenes in the case of BC and the current status of newly discovered natural products in clinical investigations.
first_indexed 2024-03-10T01:04:45Z
format Article
id doaj.art-b3dc708713344b339055d18c78ec5253
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T01:04:45Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b3dc708713344b339055d18c78ec52532023-11-23T14:28:22ZengMDPI AGMolecules1420-30492022-05-012711341210.3390/molecules27113412A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast CancerMuhammad Naeem0Muhammad Omer Iqbal1Humaira Khan2Muhammad Masood Ahmed3Muhammad Farooq4Muhammad Moeen Aadil5Mohamad Ikhwan Jamaludin6Abu Hazafa7Wan-Chi Tsai8College of Life Science, Hebei Normal University, Shijiazhuang 050024, ChinaShandong Provincial Key Laboratory of Glycoscience and Glycoengineering, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaDepartment of Chemistry, University of Management and Technology, Lahore 54770, PakistanFaculty of Pharmaceutical Sciences, Times Institute, Multan 60000, PakistanDepartment of Zoology, Faculty of Science, Ghazi University, Dera Ghazi Khan 32200, PakistanDepartment of Zoology, Faculty of Science, Ghazi University, Dera Ghazi Khan 32200, PakistanBioinspired Device and Tissue Engineering Research Group, School of Biomedical Engineering and Health Sciences, Faculty of Engineering, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, MalaysiaDepartment of Biochemistry, Faculty of Sciences, University of Agriculture Faisalabad, Faisalabad 38040, PakistanDepartment of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 807, TaiwanBreast cancer (BC) is the second leading cause of death among women, and it has become a global health issue due to the increasing number of cases. Different treatment options, including radiotherapy, surgery, chemotherapy and anti-estrogen therapy, aromatase inhibitors, anti-angiogenesis drugs, and anthracyclines, are available for BC treatment. However, due to its high occurrence and disease progression, effective therapeutic options for metastatic BC are still lacking. Considering this scenario, there is an urgent need for an effective therapeutic strategy to meet the current challenges of BC. Natural products have been screened as anticancer agents as they are cost-effective, possess low toxicity and fewer side effects, and are considered alternative therapeutic options for BC therapy. Natural products showed anticancer activities against BC through the inhibition of angiogenesis, cell migrations, proliferations, and tumor growth; cell cycle arrest by inducing apoptosis and cell death, the downstream regulation of signaling pathways (such as Notch, NF-κB, PI3K/Akt/mTOR, MAPK/ERK, and NFAT-MDM2), and the regulation of EMT processes. Natural products also acted synergistically to overcome the drug resistance issue, thus improving their efficacy as an emerging therapeutic option for BC therapy. This review focused on the emerging roles of novel natural products and derived bioactive compounds as therapeutic agents against BC. The present review also discussed the mechanism of action through signaling pathways and the synergistic approach of natural compounds to improve their efficacy. We discussed the recent in vivo and in vitro studies for exploring the overexpression of oncogenes in the case of BC and the current status of newly discovered natural products in clinical investigations.https://www.mdpi.com/1420-3049/27/11/3412breast cancernatural productstranscription factorssignaling pathwaystreatmenttherapeutic agents
spellingShingle Muhammad Naeem
Muhammad Omer Iqbal
Humaira Khan
Muhammad Masood Ahmed
Muhammad Farooq
Muhammad Moeen Aadil
Mohamad Ikhwan Jamaludin
Abu Hazafa
Wan-Chi Tsai
A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
Molecules
breast cancer
natural products
transcription factors
signaling pathways
treatment
therapeutic agents
title A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
title_full A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
title_fullStr A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
title_full_unstemmed A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
title_short A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
title_sort review of twenty years of research on the regulation of signaling pathways by natural products in breast cancer
topic breast cancer
natural products
transcription factors
signaling pathways
treatment
therapeutic agents
url https://www.mdpi.com/1420-3049/27/11/3412
work_keys_str_mv AT muhammadnaeem areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadomeriqbal areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT humairakhan areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadmasoodahmed areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadfarooq areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadmoeenaadil areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT mohamadikhwanjamaludin areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT abuhazafa areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT wanchitsai areviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadnaeem reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadomeriqbal reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT humairakhan reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadmasoodahmed reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadfarooq reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT muhammadmoeenaadil reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT mohamadikhwanjamaludin reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT abuhazafa reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer
AT wanchitsai reviewoftwentyyearsofresearchontheregulationofsignalingpathwaysbynaturalproductsinbreastcancer